Dr John Kurek
Non-Executive Director

John brings 20 years of industry experience as a Biotechnology Manager with a focus on the strategic design and implementation of drug development programs. John is the Biotechnology Investment Director of Uniseed, and is responsible for identifying new investment opportunities and managing Uniseed’s overall biotechnology and life sciences portfolio. John’s previous roles have been in ASX listed biotech companies and included Pharmaceutical Development Manager at BioDiem Ltd., managing the preclinical, clinical and regulatory aspects of BioDiem’s drug development programs, and Preclinical Development Manager at Amrad Corporation Ltd., where he was responsible for the management of preclinical drug development projects. His experience extends from drug discovery to the clinical phase of drug development.